Leads To Development (L2D) provides hands-on expertise in preclinical and non-clinical drug development that will help you rapidly build value from your innovations.
Great ideas and cutting edge science are no longer sufficient to ensure translation of your lead compounds into clinical stage products. Without expert support even strong innovations may fall at the first fence.
Drug development requires a myriad of multidisciplinary tasks that must be carried out within the confines of a complex and strict regulatory framework. Our role is to help you through this process to ensure rapid and efficient authorisation for your clinical trials, maximising the chance of project success.
TO DELIVER BIOTECH-ADAPTED SOLUTIONS
Meet us at :
• BioEurope Spring (March 2017)
• BioTrintry (May 2017)
• Oncology MEET2WIN (May 2017)
• L2D is very interested in participating in EU Framework Programme “Horizon 2020”…(read more)
• Advancement of the CDVAX FP7 Programme
9th February 2016. Leads To Development is pleased to announce … (read more)
• CASE STUDY 1
• CASE STUDY 2
ACCELERATING EARLY STAGE DEVELOPMENT
• CASE STUDY 3
ENABLING A RAPID DECISION